CDMOs

R&D

Robot arm with test tube for biological experiments

Biologics contract manufacturing: A comprehensive guide for ...

The pharmaceutical industry is undergoing a profound transformation, driven by the increasing complexity of drug development and the need for greater efficiency and cost-effectiveness.

News

Agilent builds its CDMO arm with $925m Biovectra buy

Agilent has boosted its contract development and manufacturing organisation (CDMO) capacity with a $925 million deal to buy Biovectra, a Canadian provider of fill-and-finish services and ac

News

WuXi buoyed as BIOSECURE Act is left out of US spending bill

Shares in WuXi Biologics and WuXi AppTec have tracked up after the BIOSECURE Act – which could have profound effects on their businesses in the US – was omitted from legislation due to be f

Oncology

Antibody drug conjugates – The time is now

The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs ca

Biologics contract manufacturing: A comprehensive guide for ...

Agilent builds its CDMO arm with $925m Biovectra buy

WuXi buoyed as BIOSECURE Act is left out of US spending bill

Antibody drug conjugates – The time is now

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

CDMOs

Editor's Picks